Versartis, Inc. 4
4 · Versartis, Inc. · Filed Feb 23, 2017
Insider Transaction Report
Form 4
Versartis, Inc.VSAR
Westberg Paul
Sr. VP, Business Development
Transactions
- Exercise/Conversion
Common Stock
2017-02-21$1.61/sh+18,410$29,640→ 87,954 total - Sale
Common Stock
2017-02-21$17.50/sh−12,500$218,750→ 75,454 total - Sale
Common Stock
2017-02-21$20.00/sh−5,910$118,200→ 69,544 total - Sale
Common Stock
2017-02-23$20.00/sh−6,590$131,800→ 69,544 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-02-21−3,323→ 17,074 totalExercise: $1.61Exp: 2023-07-14→ Common Stock (3,323 underlying) - Exercise/Conversion
Common Stock
2017-02-23$1.61/sh+6,590$10,610→ 76,134 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-02-21−15,087→ 506 totalExercise: $1.61Exp: 2023-01-22→ Common Stock (15,087 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2017-02-23−6,590→ 10,484 totalExercise: $1.61Exp: 2023-07-14→ Common Stock (6,590 underlying)
Footnotes (3)
- [F1]Shares sold pursuant to a 10b5-1 trading plan.
- [F2]Twenty-Five percent of the shares subject to the option become exercisable one year from 1/23/2013; the remainder become exercisable in equal monthly installments over the following three years.
- [F3]Twenty-Five percent of the shares subject to the option become exercisable one year from 7/15/2013; the remainder become exercisable in equal monthly installments over the following three years.